European Society of Cardiology: cardiovascular disease statistics 2021
Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and
expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) …
expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) …
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …
campaigns have helped to raise awareness about the impact of cardiovascular disease in …
[HTML][HTML] COVID-19 mental health impact and responses in low-income and middle-income countries: reimagining global mental health
Most of the global population live in low-income and middle-income countries (LMICs),
which have historically received a small fraction of global resources for mental health. The …
which have historically received a small fraction of global resources for mental health. The …
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
Abstract Background Cardiovascular diseases (CVDs) are one of the global leading causes
of concern due to the rising prevalence and consequence of mortality and disability with a …
of concern due to the rising prevalence and consequence of mortality and disability with a …
Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017
Aims The aim of this study was to estimate the burden and risk factors for ischaemic heart
disease (IHD) in 195 countries and territories from 1990 to 2017. Methods and results Data …
disease (IHD) in 195 countries and territories from 1990 to 2017. Methods and results Data …
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a …
Background Global estimates of the effect of common modifiable risk factors on
cardiovascular disease and mortality are largely based on data from separate studies, using …
cardiovascular disease and mortality are largely based on data from separate studies, using …
Menopause: a cardiometabolic transition
RE Nappi, P Chedraui, I Lambrinoudaki… - The Lancet Diabetes & …, 2022 - thelancet.com
Menopause is often a turning point for women's health worldwide. Increasing knowledge
from experimental data and clinical studies indicates that cardiometabolic changes can …
from experimental data and clinical studies indicates that cardiometabolic changes can …
Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy
Aims To examine the incidence of cardiovascular disease (CVD) and mortality in China and
in key subpopulations, and to estimate the population-level risks attributable to 12 common …
in key subpopulations, and to estimate the population-level risks attributable to 12 common …
The importance of gender to understand sex differences in cardiovascular disease
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
There is robust evidence of heterogeneity in underlying mechanism, manifestation …
There is robust evidence of heterogeneity in underlying mechanism, manifestation …
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial
JD Schwalm, T McCready, P Lopez-Jaramillo, K Yusoff… - The Lancet, 2019 - thelancet.com
Background Hypertension is the leading cause of cardiovascular disease globally. Despite
proven benefits, hypertension control is poor. We hypothesised that a comprehensive …
proven benefits, hypertension control is poor. We hypothesised that a comprehensive …